Barr Labs Inc Company Profile
✉ Email this page to a colleague
What is the competitive landscape for BARR LABS INC, and what generic and branded alternatives to BARR LABS INC drugs are available?
BARR LABS INC has seventeen approved drugs.
There are two tentative approvals on BARR LABS INC drugs.
Drugs and US Patents for Barr Labs Inc
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Barr Labs Inc | CLOZAPINE | clozapine | TABLET, ORALLY DISINTEGRATING;ORAL | 090308-003 | Apr 9, 2018 | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | |||||
Barr Labs Inc | CLOZAPINE | clozapine | TABLET, ORALLY DISINTEGRATING;ORAL | 090308-005 | Nov 25, 2015 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
Barr Labs Inc | ESTRADIOL | estradiol | TABLET;ORAL | 040197-001 | Oct 22, 1997 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
Barr Labs Inc | NORETHINDRONE ACETATE AND ETHINYL ESTRADIOL AND FERROUS FUMARATE | ethinyl estradiol; norethindrone acetate | TABLET;ORAL | 090938-001 | Dec 1, 2014 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
Barr Labs Inc | METHYLPHENIDATE HYDROCHLORIDE | methylphenidate hydrochloride | CAPSULE, EXTENDED RELEASE;ORAL | 079031-004 | Oct 15, 2014 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | |||||
Barr Labs Inc | OLANZAPINE | olanzapine | TABLET, ORALLY DISINTEGRATING;ORAL | 077243-003 | Jan 30, 2012 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
Barr Labs Inc | METHYLPHENIDATE HYDROCHLORIDE | methylphenidate hydrochloride | CAPSULE, EXTENDED RELEASE;ORAL | 079031-003 | Jul 13, 2012 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | |||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Here is a list of applicants with similar names.